NYSE · CDREHealthcareOrthopedic & Surgical Supplies

Cadre Holdings news

$25.53−2.03%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0

About Cadre Holdings

Cadre Holdings CEO and Chairman Sells 75,000 Shares. Should You Sell CDRE Too?
The Motley FoolJul 1, 2:35 PM ET▼ Negative

CEO's sixth stock sale in one year (1.9M shares since Nov 2025) combined with consistent stock price declines following each transaction suggests weak confidence in company prospects. The executive's substantial cash compensation indicates the sales are not driven by liquidity needs, making them a concerning signal about management's outlook on the business.

Also mentions CDRE

Articles that tag CDRE but are mainly about other companies.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology